CompoAtlas

BioCan

Natural health product licensed in Canada

Licence holder
Mapleland Enterprises Inc.
NPN or DIN-HM
80119801
Status
Active licence
Licence date
7 July 2022
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Origanum vulgare

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 250 mg

50 mgNot calculated
Arctostaphylos uva-ursi

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 350 mg

35 mgNot calculated
Coptis chinensis

Source : Rhizome

Extract : Matériel brut sec

Extraction ratio : 12:1

Dry plant equivalent : 600 mg

50 mgNot calculated

Non-medicinal ingredients

Cellulose microcristalline, Stéarate de magnésium, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Used in Herbal Medicine to help relieve symptoms associated with minor urinary tract infections, such as burning sensation and/or frequent urination. Thyme is traditionally used in Herbal Medicine to help relieve coughs (spasmolytic), the symptoms of bronchitis and mucus buildup of the (upper) respiratory tract (anti-catarrh).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80119801

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line